Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China
· Delayed Price · Currency is CNY 22.85
-0.91 (-3.83%)
Jun 10, 2025, 3:00 PM CST
SHA:688321 Revenue
Shenzhen Chipscreen Biosciences had revenue of 162.26M CNY in the quarter ending March 31, 2025, with 24.24% growth. This brings the company's revenue in the last twelve months to 689.61M, up 25.89% year-over-year. In the year 2024, Shenzhen Chipscreen Biosciences had annual revenue of 657.95M with 25.63% growth.
Revenue (ttm)
689.61M
Revenue Growth
+25.89%
P/S Ratio
13.51
Revenue / Employee
650.57K
Employees
1,057
Market Cap
9.32B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |